Seminars in hematology

Keyphrases

Publications

volume 61, number 1, 2024

Abhay Singh, Suresh Balasubramanian
The crossroads of cancer therapies and clonal hematopoiesis. Seminars in hematology 61 (1) (2024)
Ashwin Kishtagari, Robert W Corty, Valeria Visconte
Clonal hematopoiesis and autoimmunity. Seminars in hematology 61 (1) (2024)
Carlos Bravo-Perez, Carmelo Gurnari
A tower of babel of acronyms? The shadowlands of MGUS/MBL/CHIP/TCUS. Seminars in hematology 61 (1) (2024)
Yasuo Kubota, Aaron D Viny
Germline predisposition for clonal hematopoiesis. Seminars in hematology 61 (1) (2024)
Christopher J Gibson, R Coleman Lindsley, Lukasz P Gondek
Clonal hematopoiesis in the setting of hematopoietic cell transplantation. Seminars in hematology 61 (1) (2024)
Simona Pagliuca, Francesca Ferraro
Immune-driven clonal cell selection at the intersection among cancer, infections, autoimmunity and senescence. Seminars in hematology 61 (1) (2024)
Enrico Attardi, Seth J Corey, Marcin W Wlodarski
Clonal hematopoiesis in children with predisposing conditions. Seminars in hematology 61 (1) (2024)
Luca Guarnera, Babal K Jha
TET2 mutation as prototypic clonal hematopoiesis lesion. Seminars in hematology 61 (1) (2024)
Yasuo Kubota, Aaron D Viny
Germline predisposition for clonal hematopoiesis. Seminars in hematology 61 (1) (2024)
Luca Guarnera, Babal K Jha
TET2 mutation as prototypic clonal hematopoiesis lesion. Seminars in hematology 61 (1) (2024)
Jaroslaw P Maciejewski
Clonal hematopoiesis. Seminars in hematology 61 (1) (2024)
Ashwin Kishtagari, Robert W Corty, Valeria Visconte
Clonal hematopoiesis and autoimmunity. Seminars in hematology 61 (1) (2024)
Christopher J Gibson, R Coleman Lindsley, Lukasz P Gondek
Clonal hematopoiesis in the setting of hematopoietic cell transplantation. Seminars in hematology 61 (1) (2024)
Carlos Bravo-Perez, Carmelo Gurnari
A tower of babel of acronyms? The shadowlands of MGUS/MBL/CHIP/TCUS. Seminars in hematology 61 (1) (2024)
Abhay Singh, Suresh Balasubramanian
The crossroads of cancer therapies and clonal hematopoiesis. Seminars in hematology 61 (1) (2024)
Ashwin Kishtagari, Robert W Corty, Valeria Visconte
Clonal hematopoiesis and autoimmunity. Seminars in hematology 61 (1) (2024)
Christopher J Gibson, R Coleman Lindsley, Lukasz P Gondek
Clonal hematopoiesis in the setting of hematopoietic cell transplantation. Seminars in hematology 61 (1) (2024)
Jaroslaw P Maciejewski
Clonal hematopoiesis. Seminars in hematology 61 (1) (2024)
Christopher J Gibson, R Coleman Lindsley, Lukasz P Gondek
Clonal hematopoiesis in the setting of hematopoietic cell transplantation. Seminars in hematology 61 (1) (2024)

volume 61, number 2, 2024

Elizabeth R Francis, Jennifer Vu, Catherine Ostos Perez, Clare Sun
Vaccinations in patients with chronic lymphocytic leukemia. Seminars in hematology 61 (2) (2024)
Barbara Eichhorst, Elisa Ten Hacken
Special issue on chronic lymphocytic leukemia: Prognostication and therapeutic options introductory editorial. Seminars in hematology 61 (2) (2024)
Amit Sud, Erin M Parry, Catherine J Wu
The molecular map of CLL and Richter's syndrome. Seminars in hematology 61 (2) (2024)
Azra Borogovac, Tanya Siddiqi
Transforming CLL management with immunotherapy: Investigating the potential of CAR T-cells and bispecific antibodies. Seminars in hematology 61 (2) (2024)
John T Patton, Jennifer A Woyach
Targeting the B cell receptor signaling pathway in chronic lymphocytic leukemia. Seminars in hematology 61 (2) (2024)
Barbara Eichhorst, Elisa Ten Hacken
Special issue on chronic lymphocytic leukemia: Prognostication and therapeutic options introductory editorial. Seminars in hematology 61 (2) (2024)
Riccardo Moia, Gianluca Gaidano
Prognostication in chronic lymphocytic leukemia. Seminars in hematology 61 (2) (2024)
Riccardo Moia, Gianluca Gaidano
Prognostication in chronic lymphocytic leukemia. Seminars in hematology 61 (2) (2024)
Amit Sud, Erin M Parry, Catherine J Wu
The molecular map of CLL and Richter's syndrome. Seminars in hematology 61 (2) (2024)
Inhye E Ahn, Matthew S Davids
Therapeutic targeting of apoptosis in chronic lymphocytic leukemia. Seminars in hematology 61 (2) (2024)
Elizabeth R Francis, Jennifer Vu, Catherine Ostos Perez, Clare Sun
Vaccinations in patients with chronic lymphocytic leukemia. Seminars in hematology 61 (2) (2024)
John T Patton, Jennifer A Woyach
Targeting the B cell receptor signaling pathway in chronic lymphocytic leukemia. Seminars in hematology 61 (2) (2024)
Azra Borogovac, Tanya Siddiqi
Transforming CLL management with immunotherapy: Investigating the potential of CAR T-cells and bispecific antibodies. Seminars in hematology 61 (2) (2024)
Elizabeth R Francis, Jennifer Vu, Catherine Ostos Perez, Clare Sun
Vaccinations in patients with chronic lymphocytic leukemia. Seminars in hematology 61 (2) (2024)
Barbara Eichhorst, Elisa Ten Hacken
Special issue on chronic lymphocytic leukemia: Prognostication and therapeutic options introductory editorial. Seminars in hematology 61 (2) (2024)
Amit Sud, Erin M Parry, Catherine J Wu
The molecular map of CLL and Richter's syndrome. Seminars in hematology 61 (2) (2024)
Riccardo Moia, Gianluca Gaidano
Prognostication in chronic lymphocytic leukemia. Seminars in hematology 61 (2) (2024)
Elizabeth R Francis, Jennifer Vu, Catherine Ostos Perez, Clare Sun
Vaccinations in patients with chronic lymphocytic leukemia. Seminars in hematology 61 (2) (2024)
Inhye E Ahn, Matthew S Davids
Therapeutic targeting of apoptosis in chronic lymphocytic leukemia. Seminars in hematology 61 (2) (2024)
Inhye E Ahn, Matthew S Davids
Therapeutic targeting of apoptosis in chronic lymphocytic leukemia. Seminars in hematology 61 (2) (2024)
Azra Borogovac, Tanya Siddiqi
Transforming CLL management with immunotherapy: Investigating the potential of CAR T-cells and bispecific antibodies. Seminars in hematology 61 (2) (2024)

volume 61, number 3, 2024

Helga Simon-Molas, Chiara Montironi, Anna Kabanova, Eric Eldering
Metabolic reprogramming in the CLL TME; potential for new therapeutic targets. Seminars in hematology 61 (3) (2024)
Alessia Floerchinger, Martina Seiffert
Lessons learned from the Eµ-TCL1 mouse model of CLL. Seminars in hematology 61 (3) (2024)
Shih-Shih Chen
Mouse models of CLL: In vivo modeling of disease initiation, progression, and transformation. Seminars in hematology 61 (3) (2024)
Recep Bayraktar, Beatrice Fontana, George A Calin, Kinga Nemeth
miRNA Biology in Chronic Lymphocytic Leukemia. Seminars in hematology 61 (3) (2024)
Helga Simon-Molas, Chiara Montironi, Anna Kabanova, Eric Eldering
Metabolic reprogramming in the CLL TME; potential for new therapeutic targets. Seminars in hematology 61 (3) (2024)
Elisa Ten Hacken, Barbara Eichhorst
Updates on the biology of chronic lymphocytic leukemia: introductory editorial. Seminars in hematology 61 (3) (2024)
Elisa Ten Hacken, Barbara Eichhorst
Updates on the biology of chronic lymphocytic leukemia: introductory editorial. Seminars in hematology 61 (3) (2024)
Alessia Floerchinger, Martina Seiffert
Lessons learned from the Eµ-TCL1 mouse model of CLL. Seminars in hematology 61 (3) (2024)
Elena Camerini, Derk Amsen, Arnon P Kater, Fleur S Peters
The complexities of T-cell dysfunction in chronic lymphocytic leukemia. Seminars in hematology 61 (3) (2024)

volume 61, number 4, 2024

Catherine Diefenbach
Challenges for HL in the modern era: Questions to move the field forward. Seminars in hematology 61 (4) (2024)